42 CFR 10.2
§ 10.2 Summary of 340B Drug Pricing Program.
United States · 42 CFR — Public Health · Status: effective
Cite this
- Citation
- 42 CFR 10.2, § 10.2 Summary of 340B Drug Pricing Program, United States, version 1 as recorded 2026-07-09, yourstate.us, https://yourstate.us/provision/200517
- Permanent ID
ys:prov:200517@1- SHA-256
ab40f6aa9cd8b54a2931cb019a33ecc45adfe85cb858e200c65b79863891e373
The hash is SHA-256 of this version's text, with every run of whitespace collapsed to a single space and the ends trimmed. The ID always leads back here, and checking it says whether the text you cited is still the current version.
Full text
Section 340B of the PHSA instructs the Secretary of Health and Human Services to enter into agreements with manufacturers of covered outpatient drugs under which the amount to be paid to manufacturers by certain statutorily-defined covered entities does not exceed the 340B ceiling price.
Legislative history
This is a federal regulation, adopted through agency rulemaking under the Administrative Procedure Act — not enacted by a recorded vote of Congress.